nyra health

Founded 2020
Employees 10+
Primary contact
Kettenbrückengasse 23/1/12
1050 Vienna
Austria
+43 677 64320044
Previously known as myReha, nyra health combines the power of AI and evidence-based neurological research in an easy-to-use tablet app - offering a revolutionary form of therapy at the "cutting edge of science." According to the company, this approach can overcome the limitations of current neuro-therapy, expand therapy content, and enable patients to achieve their full therapeutic potential. Combined with its second product, nyra.insights, nyra health offers an unprecedented view of the patient's progress, starting with the moment of diagnosis and accompanying them on every step of the patient journey.
Founded 2020
Employees 10+
Primary contact
Kettenbrückengasse 23/1/12
1050 Vienna
Austria
+43 677 64320044

Funding 💰

Total €4.5M
Last round 🔗 €4.5M
Seed
July 22, 2023.
Select investors Wellington Partners, MassMutual Ventures, Hardlymountain

Key people 🧑‍🤝‍🧑

Highlights

  • Powerful app: nyra's CE-certified app contains over 35,000 interactive exercises to support patients after a neurological illness such as a stroke, dementia, or long COVID-19. It uses machine learning to analyze speech patterns and provide accurate, immediate feedback on pronunciation. Also included are adaptive cognitive games to create personalized therapy training plans for improving an individual's memory, speech, and attention.
  • Solid founding team: The company was founded by Philipp Schöllauf, a medical doctor specialized in neurology; Mario Zusag, a machine learning researcher previously working at Google AI and IBM Research; and Moritz Schöllauf, a lawyer with a background in regulatory affairs.
  • Expansion plans: On the heels of its seed funding round, nyra health stated that it would use the money to scale its presence in the DACH region, enhance its AI technology, and establish a firm foundation for expanding into English-speaking markets.

Video ▶️

Quotes 💬

We are witnessing a global increase in neurological disorders, ranging from stroke to dementia, largely driven by an aging population. In response to this escalating issue, nyra health has innovated a personalized therapy platform that not only addresses this pressing health concern but also offers significant scalability potential, enabling swift expansion into new markets.
Ryan Collins, Managing Partner at MassMutual Ventures 🔗
We were deeply impressed by nyra health's ability to support patients at every stage of their journey. With over 45 hospital customers in Germany and Austria, nyra health has started to demonstrate significant benefits for both patients and clinics. The company's capability to deliver Ai-guided digital support for patients throughout their often year-long recovery journey presents a unique and persuasive proposition in the healthcare sector.
Dr. Johannes Fischer, Principal at Wellington Partners 🔗
Last update: July 11, 2023